This company develops advanced tools at the intersection of microfluidic design and analytical excellence to simplify mass spectrometry sample preparation. Their platform addresses bottlenecks in biotherapeutic analysis by streamlining workflows for researchers. This technology enables scientists to accelerate discovery by removing technical barriers in sample processing.
Funding
$4.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BIFounders
Product
Problem
Current mass spectrometry workflows are hampered by slow, complex, and inefficient sample preparation methods, creating a bottleneck in bioprocess analytics. This limits the throughput of mass spec, increases costs, and delays the development of advanced biotherapeutics.
Solution
Andson Biotech's DynaCHIP is a microfluidic system designed to integrate directly into existing mass spectrometry workflows, enabling one-second sample preparation. This rapid sample preparation significantly accelerates analytical measurements, streamlines drug discovery, and reduces overall time and costs associated with bioprocess analysis. By simplifying and optimizing mass spec workflows, DynaCHIP facilitates faster assay development and enables dynamic feedback control in biomanufacturing.
Target Audience
The primary customers are biopharmaceutical companies, research institutions, and analytical labs involved in drug discovery, biotherapeutic development, and biomanufacturing.
Features
- Microfluidic technology enabling one-second sample preparation
- Seamless integration into existing mass spectrometry workflows
- High-throughput bioanalytics for accelerated results
- Simplified and optimized mass spec workflows
- Facilitates faster assay development
- Enables dynamic feedback control in biomanufacturing